US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.52

-0.5900-3.09%

Volume:12.69K

Turnover:235.35K

Market Cap:107.43M

PE:- -

High:18.62

Open:18.62

Low:18.52

Close:19.11

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:4.23

T/O Rate:0.22%

Dividend:0.71

Dividend Rate:3.86%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Pharmaceutical Procurement Rules Advance: Market Shifts from Price War to Multi-Factor Competition

BEONE MEDICINES Surges Over 4% Intraday as UOB Kay Hian Raises Target Price to HK$265

Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts

WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou

Hong Kong Stock Moves: BEONE MEDICINES Surges Nearly 4% After Earnings, Adjusted Net Profit Up 111% YoY in First Half, Solid Tumor Progress Noted

Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million

Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million

CSPC Pharmaceutical Group Stock Advances 1.5% in Hong Kong, Outperforms Competitors

Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong

Goldman Sachs Lifts INNOVENT BIO Target to HKD 111.68 on Strong H1 Product Revenue Growth

BeOne Medicines HK Shares Climb on Q2 Revenue Growth, Outlook Optimism

Interim Net Profit Surges 627%, Full-Year Revenue Guidance Raised: Beone Medicines Rebounds on Hong Kong Exchange, Huabao's Innovative Drug ETF Sees Premium Trading

BeOne Medicines Posts 627% Jump in H1 Profit; Shares Fall 5%

MT Newswires Live

Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year

Innovent Announces First Patient Dosed in Pivotal Registrational Study of Ibi363/Tak-928 (Pd-1/Il-2Α-Biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China

THOMSON REUTERS

Memory Chip Shortage Expected to Last Until 2027; SpaceX Sees $225 Billion Market Cap Wipeout

BeOne Medicines AG Reports Results for the Quarter Ended June 30 - Earnings Summary

Major A-Share Developments: Beone Medicines Reports 627% Surge in First-Half Profit

Beone Medicines Ltd. Increases 2026 Revenue Forecast to Between 44.9 Billion and 46.2 Billion Yuan

Beone Medicines Reports Record Q2 Revenue Surge and Skyrocketing Profits, Revises 2026 Full-Year Guidance Higher

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/KURE/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.52,"timestamp":1787579226422,"preClose":19.11,"halted":0,"volume":12691,"delay":0,"changeRate":-0.030873888016745153,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Trading","change":-0.59,"latestTime":"08-24 09:48:45 EDT","open":18.615,"high":18.615,"low":18.52,"amount":235351.95527200002,"amplitude":0.004971,"askPrice":18.67,"askSize":400,"bidPrice":18.34,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":19.11,"sharesOutstanding":4750002,"nav":18.99,"aum":110160584.96,"dividendRate":0.038596,"bidAskSpread":0.003071,"preHourTrading":{"tag":"盘前","latestPrice":18.5,"preClose":19.11,"latestTime":"07:56 EDT","volume":54,"amount":998.020008,"timestamp":1787572607542,"change":-0.61,"changeRate":-0.03192,"amplitude":0.005128},"postHourTrading":{"tag":"盘后","latestPrice":19.33,"preClose":19.11,"latestTime":"19:13 EDT","volume":111,"amount":2143.44,"timestamp":1787353996933,"change":0.22,"changeRate":0.011512,"amplitude":0.011512},"volumeRatio":4.232089,"impliedVol":0.3186,"impliedVolPercentile":0.6574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.232089,"shares":5800979,"dividePrice":0.7148,"high":18.615,"amplitude":0.004971,"preClose":19.11,"low":18.52,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.52,"committee":-0.6,"eps":0,"divideRate":0.038596,"volume":12691,"delay":0,"ttmEps":0,"open":18.615,"prevYearClose":17.04,"prevWeekClose":19.11,"prevMonthClose":17.28,"prevQuarterClose":15.747,"fiveDayClose":18.6,"twentyDayClose":17.3752,"sixtyDayClose":15.66},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1122643361","title":"Pharmaceutical Procurement Rules Advance: Market Shifts from Price War to Multi-Factor Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=1122643361","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122643361?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:54","pubTimestamp":1786082070,"startTime":"0","endTime":"0","summary":"Orient Securities Company Limited has released a research report analyzing the 12th round of national centralized drug procurement. The key shift is a move from \"low-price competition\" toward a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","KURE","BK0012","600958","BK1147","BK0028","03958","BK0276","BK0183","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106523435","title":"BEONE MEDICINES Surges Over 4% Intraday as UOB Kay Hian Raises Target Price to HK$265","url":"https://stock-news.laohu8.com/highlight/detail?id=1106523435","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106523435?lang=en_us&edition=fundamental","pubTime":"2026-08-07 12:00","pubTimestamp":1786075228,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) saw its shares climb more than 4% during Tuesday's trading session following the release of its quarterly results. As of the latest update, the stock was up 2.46% to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","LU0588546209.SGD","LU1969619763.USD","BK1161","BK1500","KURE","BK1588","688235","BK4585","BK1583","LU1770034418.SGD","EWH","BK4588","LU1303224171.USD","BK4526","LU0307460666.USD","LU1719994722.HKD","BK0239","ONC","BK4139","LU2328871848.SGD","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181390081","title":"Hong Kong Market Movers: Innovative Drug Stocks Rally as Earnings Season Approaches, Medical Conferences Expected to Provide Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1181390081","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181390081?lang=en_us&edition=fundamental","pubTime":"2026-08-07 11:36","pubTimestamp":1786073814,"startTime":"0","endTime":"0","summary":"Innovative drug stocks are broadly trending higher, with ZAI LAB (09688) surging 14.32% to HK$16.61, WUXI XDC (02268) climbing 9.48% to HK$60.65, and WUXI BIO (02269) advancing 6.19% to HK$43.94....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","02268","LU0823426308.USD","LU1794554557.SGD","BK1588","LU0456827905.SGD","LU0516423174.USD","LU1242518931.SGD","02269","BK1576","06978","LU0359202008.SGD","LU0708995583.HKD","LU0307460666.USD","LU0181495838.USD","LU0348825331.USD","KURE","01672","LNGR","LU0140636845.USD","BK1610","LU0320764599.SGD","LU0348735423.USD","09688","LU1242518857.USD","BK4585","159992","LU0979878070.USD","LU2039709279.SGD","LU0516422952.EUR","LU0856984785.SGD","BK1515","LU1688375341.USD","LU0051755006.USD","07666","KCAI","LU0043850808.USD","LU0516422440.USD","LU2488822045.USD","LU0516423091.SGD","LU0417516738.SGD","IE00B0JY6N72.USD","SG9999002463.SGD","LU0516422366.SGD","BK1589","MEDX","BK1574","LU0039217434.USD","BK4588","LU0819121731.USD","BK1161","BK1521","LU0572944931.SGD","LU0456846285.SGD","LU0326950275.SGD","LU0327786744.USD","SG9999002562.SGD","SG9999014674.SGD","LU0052750758.USD","LU0823426480.USD","LU0359201612.USD","LU1720050803.USD","VXUS","LU0417516902.SGD","LU0588546209.SGD","LU1880383366.USD","LU3063872942.SGD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168137106","title":"WuXi Bio Co., Ltd. gains nearly 6% in early trading, plans to acquire ChuangSheng Pharma's process development and manufacturing base in Hangzhou","url":"https://stock-news.laohu8.com/highlight/detail?id=1168137106","media":"Deep News","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168137106?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:10","pubTimestamp":1786068641,"startTime":"0","endTime":"0","summary":"WuXi Bio Co., Ltd. (02269) saw its shares rise nearly 6% in early trading, with the stock price gaining 5.70% to HK$43.74 as of press time, and a trading volume of HK$616 million.On August 7,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456846285.SGD","LU0856984785.SGD","LU0052750758.USD","LU0823426308.USD","SG9999002562.SGD","BK1574","LU0588546209.SGD","BK1576","LU0417516738.SGD","BK1589","LU0516423174.USD","BK1161","LU0348825331.USD","LU0181495838.USD","LU0516422440.USD","LU1688375341.USD","LU0140636845.USD","LU0359202008.SGD","KURE","SG9999002463.SGD","LU1242518931.SGD","LU0819121731.USD","BK1141","LU0039217434.USD","LU1242518857.USD","LU0327786744.USD","LU0516423091.SGD","LU0979878070.USD","BK1521","LU0043850808.USD","LU1720050803.USD","LU3063872942.SGD","LU2039709279.SGD","LU0307460666.USD","LU0456827905.SGD","BK1515","159938","02269","LU0516422366.SGD","LU0708995583.HKD","LU1794554557.SGD","LU1880383366.USD","LU0348735423.USD","LU0326950275.SGD","LU0516422952.EUR","LU0823426480.USD","BK1610","LU0359201612.USD","LU0320764599.SGD","LU0572944931.SGD","LU0417516902.SGD","09939","IE00B0JY6N72.USD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157467291","title":"Hong Kong Stock Moves: BEONE MEDICINES Surges Nearly 4% After Earnings, Adjusted Net Profit Up 111% YoY in First Half, Solid Tumor Progress Noted","url":"https://stock-news.laohu8.com/highlight/detail?id=1157467291","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157467291?lang=en_us&edition=fundamental","pubTime":"2026-08-07 10:04","pubTimestamp":1786068259,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) shares rose nearly 4% following its earnings release, trading up 3.66% at HK$206.8 as of press time, with a turnover of HK$362 million.On August 6, the company reported its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1969619763.USD","BK4585","06160","BK1583","ONC","688235","LU1303224171.USD","BK4139","BK4588","LU1719994722.HKD","KURE","BK1161","LU1251922891.USD","KCAI","LU2328871848.SGD","BK0239","LU0588546209.SGD","VXUS","BK1500","LU1770034418.SGD","BK1588","BK4526","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657697186","title":"Transcenta Agrees to Sell CDMO Assets to WuXi Biologics Unit for RMB 190 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657697186","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657697186?lang=en_us&edition=fundamental","pubTime":"2026-08-07 06:31","pubTimestamp":1786055477,"startTime":"0","endTime":"0","summary":"Transcenta agrees to sell CDMO assets to WuXi Biologics unit for RMB 190 millionTranscenta agreed to sell its Hangzhou CDMO manufacturing assets to WuXi Biologics’ Hangzhou unit for RMB 190 million, s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL63fqMJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU3063872942.SGD","BK1161","LU0417516738.SGD","LU0588546209.SGD","LU0823426480.USD","LU0856984785.SGD","02269","LU2039709279.SGD","SG9999002463.SGD","LU0819121731.USD","LU0417516902.SGD","LU1880383366.USD","LU0307460666.USD","SG9999002562.SGD","BK1589","KURE","LU0320764599.SGD","LU1720050803.USD","BK1576","LU0516422366.SGD","LU0456846285.SGD","LU1242518931.SGD","BK1521","LU0979878070.USD","LU0823426308.USD","LU0348735423.USD","06628","LU0572944931.SGD","LU0516422440.USD","LU1794554557.SGD","LU0327786744.USD","LU0140636845.USD","LU0039217434.USD","LU0456827905.SGD","LU0181495838.USD","BK1141","LU0359201612.USD","LU0516422952.EUR","IE00B0JY6N72.USD","LU0516423091.SGD","LU0326950275.SGD","LU0051755006.USD","LU0043850808.USD","LU0348825331.USD","LU0359202008.SGD","LU0516423174.USD","LU0708995583.HKD","BK1610","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657636039","title":"Whitehawk Q2 FY26 Net Loss Narrows to $16.64 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657636039","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657636039?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:06","pubTimestamp":1786018009,"startTime":"0","endTime":"0","summary":"Whitehawk Q2 FY26 net loss narrows to $16.64 millionWhitehawk Therapeutics posted a Q2 net loss of USD 16.6 million, narrowing from USD 52.6 million a year earlier.R&D spending fell to USD 12.9 millio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL5z2sTn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1242518857.USD","LU3063872942.SGD","WHWK","BK4139","LU0417516738.SGD","LU0823426480.USD","LU0856984785.SGD","02269","LU2039709279.SGD","SG9999002463.SGD","LU0819121731.USD","LU0417516902.SGD","LU1880383366.USD","LU0307460666.USD","SG9999002562.SGD","BK1589","KURE","LU0320764599.SGD","LU1720050803.USD","BK1576","LU0516422366.SGD","LU0456846285.SGD","LU1242518931.SGD","BK1521","LU0979878070.USD","LU0823426308.USD","LU0348735423.USD","LU0572944931.SGD","LU0516422440.USD","LU1794554557.SGD","LU0327786744.USD","LU0140636845.USD","LU0039217434.USD","LU0456827905.SGD","LU0181495838.USD","BK1141","LU0359201612.USD","LU0516422952.EUR","IE00B0JY6N72.USD","LU0516423091.SGD","LU0326950275.SGD","LU0051755006.USD","LU0043850808.USD","LU0348825331.USD","LU0359202008.SGD","LU0516423174.USD","LU0708995583.HKD","BK1610","LU1688375341.USD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657686322","title":"CSPC Pharmaceutical Group Stock Advances 1.5% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2657686322","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657686322?lang=en_us&edition=fundamental","pubTime":"2026-08-06 16:33","pubTimestamp":1786005180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rose 1.5% to 8.50 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.5% to 25530.28.CSPC Pharmaceutical Group Ltd. closed 27% short of its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock outperformed some of its competitors, as Sino Biopharmaceutical Ltd. rose 0.9%, SSY Group Ltd. fell 2.3%, and United Laboratories International Holdings Ltd. fell 1.7%.Trading volume totaled 55.1 million shares, compared to the 50-day average of 106.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YR35.GBP","LU1328277881.USD","LU1226287792.SGD","LU1813983027.USD","LU1152091754.HKD","IE00B543WZ88.USD","LU1993786604.SGD","BK1191","IE0008368742.USD","LU2039709279.SGD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","KURE","LU0501845795.SGD","LU0072913022.USD","LU0067412154.USD","LU1951186391.HKD","LU0140636845.USD","LU0314109678.HKD","SG9999004220.SGD","LU1807302812.USD","LU1960683339.HKD","LU1226287529.USD","LU1226288170.HKD","BK1515","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YT58.USD","BK1521","LU0315179316.USD","HK0000165453.HKD","LU1226287875.USD","01093","LU1226288253.USD","LU0880133367.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU1152091168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657168637","title":"Wuxi Biologics (Cayman) Stock Advances 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2657168637","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657168637?lang=en_us&edition=fundamental","pubTime":"2026-08-06 16:33","pubTimestamp":1786005180,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rallied 1.9% to 41.38 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.5% to 25530.28.This was the stock's fifth consecutive day of gains.Wuxi Biologics  Inc. closed 6.0% below its 52-week high of HK$44.00, which the company achieved Feb. 12.Trading volume totaled 37.4 million shares, compared to the 50-day average of 32.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0572944931.SGD","LU0417516902.SGD","SG9999002463.SGD","LU0359202008.SGD","LU0516422366.SGD","LU0417516738.SGD","LU0039217434.USD","LU0456846285.SGD","KURE","LU0051755006.USD","LU0348825331.USD","LU0516423174.USD","LU0588546209.SGD","LU0823426480.USD","LU1720050803.USD","BK1576","LU2039709279.SGD","LU3063872942.SGD","BK1589","LU0516422952.EUR","LU0823426308.USD","LU0327786744.USD","LU0456827905.SGD","LU0359201612.USD","LU0043850808.USD","LU0326950275.SGD","LU1794554557.SGD","LU0856984785.SGD","LU1880383366.USD","LU0516423091.SGD","LU0819121731.USD","LU0348735423.USD","SG9999002562.SGD","LU1242518931.SGD","BK1521","LU0516422440.USD","LU0140636845.USD","LU1688375341.USD","LU0181495838.USD","LU0307460666.USD","LU0979878070.USD","LU0320764599.SGD","BK1610","02269","BK1141","IE00B0JY6N72.USD","LU1242518857.USD","LU0708995583.HKD","LU0052750758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146046110","title":"Goldman Sachs Lifts INNOVENT BIO Target to HKD 111.68 on Strong H1 Product Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1146046110","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146046110?lang=en_us&edition=fundamental","pubTime":"2026-08-06 15:44","pubTimestamp":1786002257,"startTime":"0","endTime":"0","summary":"Goldman Sachs has released a report indicating that INNOVENT BIO (01801) achieved product revenue exceeding RMB 8.2 billion in the first half of the year, representing a 55% year-on-year increase. In...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","LU2242644610.SGD","LU0455707207.USD","BK1589","KURE","LU2097828474.EUR","LU2097828557.USD","LU2097828714.EUR","BK1583","BK1161","LU2097828631.EUR","01801","HK0000165453.HKD","LU1969619763.USD","LU2097828805.USD","LU2488822045.USD","EWH","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657362506","title":"BeOne Medicines HK Shares Climb on Q2 Revenue Growth, Outlook Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2657362506","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657362506?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:41","pubTimestamp":1785987693,"startTime":"0","endTime":"0","summary":"BUZZ-BeOne Medicines HK shares climb on Q2 revenue growth, outlook optimism** Hong Kong shares of BeOne Medicines AG6160.HKclimb 1.5% to HK$201.6, their highest level since July 30 and extending gains","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N44302Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK1583","LU1303224171.USD","KURE","LU1969619763.USD","LU1719994722.HKD","LU1770034418.SGD","BK1161","BK1588","06160","LU0307460666.USD","LU0588546209.SGD","LU2328871848.SGD","688235","LU1251922891.USD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143571336","title":"Interim Net Profit Surges 627%, Full-Year Revenue Guidance Raised: Beone Medicines Rebounds on Hong Kong Exchange, Huabao's Innovative Drug ETF Sees Premium Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1143571336","media":"Deep News","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143571336?lang=en_us&edition=fundamental","pubTime":"2026-08-06 11:30","pubTimestamp":1785987038,"startTime":"0","endTime":"0","summary":"Beone Medicines (06160.HK) has delivered a standout financial report, reinforcing the strong momentum in the innovative drug sector. Following the impressive results from CXO leader WuXi AppTec, the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","LU1251922891.USD","159316","BK1588","KURE","LU1303224171.USD","BK4588","ONC","LU0588546209.SGD","520880","BK4139","BK4585","LU0307460666.USD","FLHK","LU2328871848.SGD","06160","LU1770034418.SGD","KCAI","BK4526","LU1719994722.HKD","BK0239","BK1583","BK1161","LU1969619763.USD","688235","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657053465","title":"BeOne Medicines Posts 627% Jump in H1 Profit; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657053465","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657053465?lang=en_us&edition=fundamental","pubTime":"2026-08-06 10:47","pubTimestamp":1785984449,"startTime":"0","endTime":"0","summary":"BeOne Medicines  posted first-half attributable net profit of 3.27 billion yuan, up 627% from 449.8 million yuan the previous year.Basic earnings per share jumped to 2.26 yuan from 0.32 yuan, according to a Thursday filing with the Shanghai bourse.Operating revenue climbed 27% year over year to 22.2 billion yuan from 17.5 billion yuan.Shares of the oncology company fell 5% in recent trade on the Shanghai bourse.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1500","BK1588","LU1770034418.SGD","FCA","LU0307460666.USD","LU0588546209.SGD","LU1719994722.HKD","LU1969619763.USD","LU2328871848.SGD","MDCO","688235","BK1583","06160","LU1303224171.USD","LU1251922891.USD","KURE","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174657246","title":"Hong Kong Stock Exchange News Highlights: Beone Medicines Sees 111% Surge in Adjusted Net Profit for First Half of the Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1174657246","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174657246?lang=en_us&edition=fundamental","pubTime":"2026-08-06 09:11","pubTimestamp":1785978684,"startTime":"0","endTime":"0","summary":"Major DevelopmentsCSPC Pharmaceutical Group (01093) has signed a joint venture agreement with AstraZeneca to deepen their strategic collaboration through the establishment of a new company.YouRan...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880383366.USD","LU0072913022.USD","LU0345776255.USD","LU0499858602.USD","LU0605514214.HKD","BK1618","LU1961090484.USD","LU0441854154.USD","LU0143863784.USD","LU0650527681.SGD","LU0823397103.USD","01810","LU1152091168.USD","HXXD.SI","LU0463099449.HKD","BK4139","LU0164872284.USD","BK0239","SG9999001093.SGD","BK1583","06160","LU0561508036.HKD","LU1226288253.USD","LU0675040207.SGD","IE00BWDBJ730.SGD","LU2476274308.USD","BK4585","BK4588","LU1770034418.SGD","LU0880133367.SGD","LU0918141705.HKD","LU1115378108.SGD","LU0348814723.USD","LU0417516738.SGD","LU1868838027.USD","LU2399975544.HKD","BK1607","KURE","LU0082770016.USD","LU2778985437.USD","BK1212","LU0140636845.USD","IE0034224299.USD","XIACY","01093","LU0449509016.USD","LU2039709279.SGD","LU0823426308.USD","LU0588546209.SGD","LU0823413587.USD","LU0594300179.USD","LU0594300419.USD","LU0307460666.USD","LU2097828714.EUR","LU0067412154.USD","BK1237","81810","BK1506","LU0499858438.USD","IE00B19Z5X02.USD","LU1105468828.SGD","LU0169518387.USD","IE00BZ08YR35.GBP","LU0797268264.HKD","LU0210526637.USD","BK1521","MIUmain","IE0008369823.USD","LU0327786744.USD","LU0244354667.USD","LU0348816934.USD","LU0634319403.HKD","LU0348827113.USD","VXUS","LU0359202008.SGD","BK1587","SG9999004220.SGD","LU0456827905.SGD","IE00B0169L03.USD","LU1807302812.USD","IE00BZ08YT58.USD","LU0620787316.HKD","BK1549","LU2087589342.USD","LU1868837565.USD","LU0417516902.SGD","BK1193","LU0164880469.USD","LU1719994722.HKD","LU0231483743.USD","LU1226288170.HKD","LU0531970944.HKD","LU1993786604.SGD","IE00BZ08YS42.EUR","BK1191","LU1226287792.SGD","LU1720050803.USD","LU0540923850.HKD","LU0700851271.USD","LU0326950275.SGD","LU2152927971.USD","LU0823426480.USD","IE00B5MMRT66.SGD","BK1588","LU1956131251.USD","LU0823040885.USD","LU0918141887.USD","BK1523","LU0320764599.SGD","00220","LU0640798160.USD","KCAI","LU1813983027.USD","LU2097828805.USD","LU1303224171.USD","LU1323998911.USD","ONC","LU0214875030.USD","LU0235996351.USD","LU0449515922.USD","BK1610","LU1808992512.USD","LU1981816686.USD","LU0501845795.SGD","LU0823039010.USD","LU0871576103.HKD","IE0008368742.USD","688235","LU0611395673.USD","LU1251922891.USD","LU0823397285.USD","BK1575","LU0082770016.SGD","LU1226287875.USD","LU2097828557.USD","LU0359201612.USD","LU1008478684.HKD","LU0054450605.USD","LU0164865239.USD","LU0039217434.USD","LU0348825331.USD","LU0456846285.SGD","LU0572944931.SGD","LU1969619763.USD","LU2328871848.SGD","LU0149721374.USD","LU0708995583.HKD","LU0052750758.USD","LU0348735423.USD","LU0823041008.USD","LU0315179316.USD","09858","LU1951186391.HKD","LU2226246903.HKD","LU0051755006.USD","BK1615","LU0359201885.HKD","HK0000165453.HKD","HK0000286598.CNH","LU0117841782.USD","LU1794554557.SGD","LU1481107354.HKD","LU2097828474.EUR","LU2097828631.EUR","LU0823413660.USD","SG9999002463.SGD","BK1515","IE00B3M56506.USD","DRGN","LU0254981946.USD","IE0032431581.USD","LU0531971595.HKD","BK1589","LU0593848301.USD","LU0211977185.USD","LU2294711473.HKD","LU1226287529.USD","LU0084288322.USD","LU0345775950.USD","IE00B543WZ88.USD","LU1770036033.HKD","BK4526","BK1161","LU0314109678.HKD","LU1328277881.USD","SG9999003461.SGD","LU0143863198.USD","LU1282648689.USD","LU1960683339.HKD","BK1500","LU2476274720.SGD","LU1152091754.HKD","LU0823038988.USD","LU1880383440.USD","LU1023057109.AUD","IE00BQJZWZ67.USD","IE00B031HY20.USD","LU1188198961.HKD","LU0164939612.USD","BK1502","LU2257852520.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657577353","title":"Innovent Announces First Patient Dosed in Pivotal Registrational Study of Ibi363/Tak-928 (Pd-1/Il-2Α-Biased Bispecific Fusion Protein) in Combination with Bevacizumab in Late-Line Advanced Colorectal Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2657577353","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657577353?lang=en_us&edition=fundamental","pubTime":"2026-08-06 08:00","pubTimestamp":1785974402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA6RJNM8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01801","LU2328871848.SGD","LU0502904849.HKD","HK0000165453.HKD","LU2097828631.EUR","LU2488822045.USD","BK1589","LU2097828557.USD","KURE","LU2242644610.SGD","LU0455707207.USD","LU2097828474.EUR","LU1969619763.USD","LU2097828805.USD","BK1583","LU2097828714.EUR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155133335","title":"Memory Chip Shortage Expected to Last Until 2027; SpaceX Sees $225 Billion Market Cap Wipeout","url":"https://stock-news.laohu8.com/highlight/detail?id=1155133335","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155133335?lang=en_us&edition=fundamental","pubTime":"2026-08-06 07:45","pubTimestamp":1785973529,"startTime":"0","endTime":"0","summary":"According to a tech media report on Tuesday, the memory chip supply shortage is expected to persist until 2027, with industry sources revealing that the three major memory manufacturers have...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MARS","LU1861558580.USD","UFO","LU1969619763.USD","SPAX","BK4585","DXYZ","06160","BK1583","LU2360107168.USD","WARP","ORBX","SPCM","SPCQ","LU1861215975.USD","LU2290526834.HKD","SSPC","BK4615","DRAL","LU1303224171.USD","BK4588","XOVR","SPCF","DRAM","LU1719994722.HKD","LOFF","KURE","BK1161","LU1251922891.USD","SNK","LU1861220033.SGD","RAM","KCAI","LU2328871848.SGD","BK1117","00100","LU0588546209.SGD","SPCH","VXUS","BK1500","LU1770034418.SGD","LU1861559042.SGD","SPCU","BK4089","SPCX","BK1588","SPCG","SPAL","WSPC","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657526894","title":"BeOne Medicines AG Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657526894","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657526894?lang=en_us&edition=fundamental","pubTime":"2026-08-05 23:42","pubTimestamp":1785944527,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG reports results for the quarter ended June 30 - Earnings SummaryBeOne Medicines AG6160.HKreported quarterly adjusted earnings of 16 cents per share for the quarter ended June 30, hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4422O7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1770034418.SGD","LU2328871848.SGD","LU0307460666.USD","BK1161","LU0588546209.SGD","LU1969619763.USD","LU1719994722.HKD","KURE","BK1583","LU1251922891.USD","BK1588","LU1303224171.USD","06160","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102813061","title":"Major A-Share Developments: Beone Medicines Reports 627% Surge in First-Half Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=1102813061","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102813061?lang=en_us&edition=fundamental","pubTime":"2026-08-05 20:50","pubTimestamp":1785934242,"startTime":"0","endTime":"0","summary":"Market Focus for Today China Merchants Energy Shipping (601872) announced on August 5th that it plans to construct five new Aframax tankers. Through its wholly-owned subsidiary, Haiming Shipping...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","LU1719994722.HKD","BK1583","LU1303224171.USD","BK1588","BK1500","LU0307460666.USD","06160","399300","LU2328871848.SGD","BK4585","KURE","BK4526","BK1161","BK4139","ONC","LU1770034418.SGD","BK4588","LU0588546209.SGD","159982","LU1969619763.USD","LU1251922891.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162137602","title":"Beone Medicines Ltd. Increases 2026 Revenue Forecast to Between 44.9 Billion and 46.2 Billion Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1162137602","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162137602?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:42","pubTimestamp":1785930133,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd. (688235.SH) has issued a notice announcing revisions to its 2026 operating performance forecast. The company now expects annual revenue for 2026 to fall between 44.9 billion yuan...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1251922891.USD","BK1161","BK4526","BK1588","LU2328871848.SGD","BK0239","BK1583","KURE","LU1969619763.USD","LU1719994722.HKD","BK1500","BK4139","BK4585","LU0588546209.SGD","ONC","688235","BK4588","06160","LU1303224171.USD","LU0307460666.USD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116587955","title":"Beone Medicines Reports Record Q2 Revenue Surge and Skyrocketing Profits, Revises 2026 Full-Year Guidance Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1116587955","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116587955?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:28","pubTimestamp":1785925729,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd. delivered a strong second-quarter performance, with its core commercial products continuing to expand. The company's revenue, profits, and cash flow all improved simultaneously,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","LU0307460666.USD","LU0588546209.SGD","BK4526","BK1588","LU2328871848.SGD","ONC","BK1583","688235","KURE","BK4585","LU1719994722.HKD","BK1500","LU1770034418.SGD","BK0239","BK1161","LU1969619763.USD","LU1251922891.USD","LU1303224171.USD","06160"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}